Atlas Trials

Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg)

Clinical trial NCT00240539 · COMPLETED

Trial details

NCT number
NCT00240539
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis B
Start date
2003-10-01
Primary completion
2008-07-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.